Member Info for mulledwine

Strategic highlights · Continued to develop strong market positions in construction sectors and to grow investment in regeneration · Our creative partnering is helping public and private sector clients overcome funding constraints · Strong relationships driving increased revenue from repeat clients and from existing frameworks · Sale of mature investments to recycle capital into new projects

Financial highlights · Solid performance in difficult markets, in line with expectations · Interim dividend maintained at 12p, reflecting balance sheet strength and confidence on medium-term outlook · Margins held up well given market conditions, due to focus on operational discipline · Average net debt balance of £36m (2011: cash of £43m) reflecting investment in regeneration and reduced levels of cash generated from construction activities

http://www.investegate.co.uk/Article.aspx?id=201208060700063253J

Credit Suisse has downgraded its recommendation for British Airways and Iberia owner International Consolidated Airlines Group, otherwise known as IAG, from 'outperform' to 'neutral' on the back of risks to 2013 consensus estimates. IAG reported a second-quarter loss of €4m last week and revealed guidance of a small operating loss for the full year. As such, the broker has cut its forecast of €143m profit to a loss of €82m and reduced its 2013 earnings before interest and tax (EBIT) estimate from €695m to €319m pre-exceptionals. The target price comes down from 176p to 160p. Credit Suisse reckons that earnings momentum will remain "soft" in the short term despite the strength in trading at British Airways.

ANGLOGOLD ASHANTI DECLARES A DIVIDEND OF 100 SOUTH AFRICAN CENTS PER SHARE FOR THE QUARTER ENDED 30 JUNE 2012

Charles Skinner, Chief Executive of Restore plc, said: "The divestment of Peter Cox has been a strategic goal for some time. It has become an increasingly strong business over the last two years, but it did not fit with the rest of our activities. Its disposal completes the restructuring of the Group, and leaves Restore solely focused on office services, where we continue to make good progress. I expect Peter Cox to thrive as an independent business and wish Harvey and his team the very best for the future."

Disposal of Peter Cox Limited Restore plc ("Restore" or "the Company"), the UK office services provider, today announces that it has sold Peter Cox Limited ("Peter Cox"), its building repair business, to Castlefield House Limited for a total consideration of £3.6 million. Castlefield House Limited is a company controlled by Harvey Samson, previously Finance Director of Restore, who on 18 June 2012 reverted to his previous role as a consultant to the Company. The disposal is consistent with Restore's strategy of focusing solely on office services, where it is now market leader in office relocations and number three in UK records management. The net proceeds from the disposal will be used to reduce debt and fund further bolt-on acquisitions in office services. Under the terms of the transaction, Restore received £2.2 million at completion and will receive a further £500,000 at the year end. Three further payments of £300,000 each will be made in September 2013, 2014 and 2015. There are no performance criteria related to the deferred payments. For the year to December 2011, Peter Cox recorded profit before tax of £0.8 million on turnover of £15.2 million. Net assets at completion were £1.4 million. The acquisition is a related party transaction pursuant to the AIM Rules for Companies, because Harvey Samson was until recently the Finance Director of Restore. The directors, having consulted with Cenkos Securities plc, the Company's nominated adviser, consider that the terms of the acquisition are fair and reasonable insofar as Restore's shareholders are concerned.

http://www.investegate.co.uk/Article.aspx?id=201208060700053211J

In recognition of these considerable sacrifices the Directors intend in due course to make additional grants of share options to the individuals concerned and to rebase the exercise price of any existing options that they currently hold. As a consequence of this reduction in the Company's liabilities, the significant reduction in its overhead base and of the rising sales trend, the Directors believe that the Company currently has sufficient cash resources to meet its immediate requirements. However, for the sake of prudence, the Directors will continue to explore various options by which the Company's balance sheet can be strengthened. The Directors believe that with only a relatively small amount of additional capital the Company will be robustly positioned to grow into the future. One of the principal objectives of the Company's listing on AIM was to provide it with access to development capital as the business grew. However, it has become apparent that in the current market environment this objective cannot be met and as a consequence the Board no longer feels able to justify the continued costs associated with the Company's admission to AIM. The Directors therefore intend to write to shareholders in the near future to convene an extraordinary general meeting of the Company at which they will propose a resolution to cancel the admission of the Company's ordinary shares to trading on AIM. Under the AIM Rules it is a requirement that cancellation of admission to trading on AIM requires approval by not less than 75 per cent of votes cast by shareholders in a general meeting. If the resolution is passed in an extraordinary general meeting by the requisite majority and the Company de-lists from AIM it would be the Directors' intention that the Company continues to maintain an appropriate level of corporate governance by, inter alia, retaining the services of a non-executive director on the Board, and by keeping shareholders informed by sending them copies of the interim and the final accounts and through periodic updates on the Company's website at www.3ddiagnosticimaging.com.

Rising Sales Trend, Major Cost Cutting Exercise, Proposed De-listing from AIM, Ongoing Corporate Governance The Directors are pleased to advise that the Company's wholly owned subsidiary, CarieScan Limited ("CarieScan"), has experienced an increase in sales revenues, albeit from a modest base, in each of the first six months of the current year. The Directors believe that an upward trend in sales revenues will continue in the second half of the year. Notwithstanding this rising trend the Directors have begun to implement a major cost cutting exercise which they anticipate will reduce the Company's monthly overhead base to less than £60,000. As a part of this exercise the executive Directors, Graham Lay (Chief Executive Officer) and Oliver Cooke (Chief Financial Officer), have agreed to reduce their annual remuneration by 60% and 80% respectively and David Snow, the Company's Non-Executive Chairman, has waived 100% of his annual remuneration. A small number of redundancies have also been made and all remaining members of staff have agreed to reduce their annual remuneration by an average of 25%. Over the past fifteen month period the executive Directors have deferred one third of their salaries and both the current and the previous Non-Executive Chairman have deferred the whole of their remuneration. Each of the Directors has now agreed to waive the amount due to him by the Company. As a consequence the amounts that had previously been accrued to the Company's profit and loss account will now be written back and the cash liability expunged.

http://www.investegate.co.uk/Article.aspx?id=201208060700063267J

GETECH's Chief Executive, Raymond Wolfson, commented, "While we had anticipated further contracts in the short term, it is nevertheless very satisfying when they are confirmed. Each new commitment is significant for us and continues to reinforce the momentum that we perceive to be building around our Global Programmes. This further sale will provide a strong start to the new financial year and helps provide improved visibility of income."

Further sale of Global Programmes GETECH, the oil services business specialising in the provision of exploration data and geological exploration studies, announces a further sale of its Global Programmes. GETECH announced in April that it anticipated signing a number of further clients for its Global Programmes in the near future. A further agreement has now been completed bringing the total number of clients who have made a full commitment to six. The Global Programmes include a variety of deliverables, some of which have already been purchased in part by clients. The price paid by new sponsors therefore varies depending on which elements have already been purchased, but the contract being reported on here is worth in excess of £0.5m. The Global Programmes is a major strategic initiative in which the Company has been investing over recent years. The sponsors, which are major, well known companies with international interests, fund a three year programme of work, of which the first year's work was completed earlier this year. Their initial funding commitment runs through until mid 2014. The aim of the Global Programmes is to provide exploration teams in oil and gas companies with a robust and constantly updated platform which supports their understanding, investigation and risking of new areas of interest. The Global Programmes encompass a range of products that build on GETECH's traditional strengths in potential field geophysics as well as our unique global plate model and palaeogeographic mapping techniques. These provide insights into the shape and evolution of sedimentary basins, and the geographic context of the deposition within those basins; this includes reconstructions of past rivers, landscapes and sediment distributions. The palaeogeographies will then be used as the boundary conditions for state-of-the-art palaeoclimate, ocean and tide modelling.

http://www.investegate.co.uk/Article.aspx?id=201208060700063279J

Commenting, Faisal Rahmatallah, Executive Chairman, said: "Our OEM customers are continuing to invest in new products and product enhancements despite the poor macroeconomic backdrop, so generating additional demand for the specialist bearing assemblies that we design and manufacture."

Contract wins Plastics Capital plc (AIM: PLA), the niche plastics products group, announces new contract wins worth approximately £0.5m on an annualised basis. Two design projects for plastic ball bearing assemblies have been successfully converted into orders. The first is for a leading US security camera manufacturer and the other is for an Israeli manufacturer of swimming pool equipment. It is expected that these projects will deliver incremental annualised sales of approximately £0.25m. In addition, an important project for a major Korean manufacturer of security cameras is being accelerated for launch by the end of this calendar year and should contribute approximately £0.25m of sales on an annualised basis.

http://www.investegate.co.uk/Article.aspx?id=201208060700063269J

Outlook PuriCore's business mix has been designed to deliver both robust growth and cash generation, and the Company continues to maintain a prudent approach to costs. In the Supermarket Retail sector, an aggressive sales approach continues to drive top-line growth and market share expansion. In addition, development work is underway to launch a new FloraFresh bottled formulation for floral care to meet growing customer demand. In the UK, the Board is cautiously optimistic regarding 2012 as this business remains focused on prudent cost controls and margins whilst continuing to increase recurring revenues. PuriCore Endoscopy will also aim to capitalise on recurring revenues from the new surgical consumables catalogue now in the portfolio following the strategic acquisition of Monmouth Surgical. In the Wound Care market, PuriCore remains focused on driving sales by aggressively pursuing new opportunities, including new formulations, geographies, and partnerships to expand the Company's market reach and product adoption. Lastly, PuriCore will continue to invest in its R&D programme for ActiVita Agriculture Solution, with a view to attracting suitable partners for this promising application.

Michael Ashton, Executive Chairman, said: "PuriCore continued to be EBITDA profitable and cash flow positive from operations across the business during the first half of the year, delivered strong sales, and continued to reduce operating costs. For the remainder of the year, we will continue to drive sales aggressively in all business units, prudently control costs, and pursue potentially lucrative business development opportunities to continue to grow the company and build shareholder value." PuriCore will host a conference call for investors and analysts today at 2.00 pm BST, and a recording will be available on the Company's website at www.puricore.com. For details of the call please contact FTI Consulting or Sage Strategic Marketing. *Earnings before interest, tax, depreciation, and amortisation.

Business and Operational Highlights · Supermarket Retail: sales of 754 new Sterilox Fresh and FloraFresh Systems from existing and new customers bringing to total of 6,101 Systems sold or leased to US and Canadian supermarkets · Endoscopy: recurring revenues up 8% (10% at constant currency), accounting for 77% of revenues · Wound Care: strong organic and distribution sales · University of Oxford received £500,000 to study PuriCore's ActiVita Agricultural Solution